TMOD-18. EXPLORING THE FACTORS LEAD TO SUCCESS OF CAR T-CELL THERAPY IN GLIOBLASTOMA WITH COMPUTATIONAL MODELING AND IN VITRO DATA

Chimeric antigen receptor (CAR) T-cell therapy is an emerging targeted immunotherapy which has shown success in liquid cancers such as leukemias. CAR T-cells are also being used for the treatment of solid tumors such as glioblastoma, which is a primary brain tumor. Ongoing phase I trials have been d...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Sahoo, Prativa, Yang, Xin, Abler, Daniel, Maestrini, Davide, Adhikarla, Vikram, Brown, Christine E, Rockne, Russell
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Tumor Models
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846140/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1117
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller